For example, astragaloside IV was reported to attenuate podocyte apoptosis by inhibiting oxidative stress via activating the PPARγ-Klotho-FoxO1 signaling pathway, thereby ameliorating diabetic nephropathy (Xing et al., 2021). This evidence concerns the gene PPARG and diabetic kidney disease.